Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-Interferon: An observational study

Medicine & Life Sciences

• Progressive Multifocal Leukoencephalopathy 100%
• Interferon-alpha 72%
• Observational Studies 56%
• HIV 50%
• Survival 40%
• CD4 Lymphocyte Count 8%
• Dysarthria 5%
• Central Nervous System Infections 5%
• Survivorship 5%
• Time and Motion Studies 5%
• Aphasia 4%
• Controlled Clinical Trials 4%
• Paresis 4%
• Memory Disorders 4%
• Ataxia 4%
• Deglutition Disorders 4%
• Acquired Immunodeficiency Syndrome 3%
• Disease Progression 3%
• Therapeutics 1%